B. Gülekli, "Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation," American Society for Reproductive Medicine , vol.82, no.5, pp.1458-1459, 2004
Gülekli, B. 2004. Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation. American Society for Reproductive Medicine , vol.82, no.5 , 1458-1459.
Gülekli, B., (2004). Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation. American Society for Reproductive Medicine , vol.82, no.5, 1458-1459.
Gülekli, BÜLENT. "Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation," American Society for Reproductive Medicine , vol.82, no.5, 1458-1459, 2004
Gülekli, BÜLENT. "Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation." American Society for Reproductive Medicine , vol.82, no.5, pp.1458-1459, 2004
Gülekli, B. (2004) . "Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation." American Society for Reproductive Medicine , vol.82, no.5, pp.1458-1459.
@article{article, author={BÜLENT GÜLEKLİ}, title={Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation}, journal={American Society for Reproductive Medicine}, year=2004, pages={1458-1459} }